Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02904096 · ClinicalTrials.gov registry record · NA
Radiesse® Safety Study For the Treatment of Hands
A NA study of Volume Loss in the Dorsum of the Hand, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 9
- Study locations
NCT02904096 is a NA study of Volume Loss in the Dorsum of the Hand that has completed, run by Merz North America. The registered enrollment target is 256 participants. The trial reports 9 study locations across 4 states.
The verdict
NCT02904096, a NA study of Volume Loss in the Dorsum of the Hand, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 9
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety of Radiesse implantation for very severe volume loss in the dorsum of the hand at 6 months after treatment.
Conditions Studied
Interventions
- DEVICE Radiesse injectable implant and 2% lidocaine HCL
Study Locations (9)
California
- Merz Investigative Site #0010393 - Sacramento
- Merz Investigative Site #0010321 - San Diego
- Merz Investigative Site #0010358 - Vista
- Merz Investigative Site #0010099 - West Hollywood
New York
- Merz Investigative Site #0010405 - New York
- Merz Investigative Site #0010406 - New York
Texas
- Merz Investigative Site #0010322 - Austin
- Merz Investigative Site #0010125 - Plano
Washington
- Merz Investigative Site #0010392 - Spokane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2016-06-10 |
| Est. Completion | 2019-01-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02904096
The ClinicalTrials.gov registry entry for NCT02904096 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Volume Loss in the Dorsum of the Hand appearing as the primary indexed condition, and to 1 intervention - of which Radiesse injectable implant and 2% lidocaine HCL is the first listed.
NCT02904096 reports 9 study locations spanning 4 distinct geographic areas - top geographies include California, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT02904096 about?
NCT02904096 is a clinical study titled "Radiesse® Safety Study For the Treatment of Hands". The primary objective of this study is to evaluate the safety of Radiesse implantation for very severe volume loss in the dorsum of the hand at 6 months after treatment.
What is the current status of trial NCT02904096?
This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2016-06-10. Estimated completion is 2019-01-09.
What conditions does trial NCT02904096 study?
This clinical trial studies the following conditions: Volume Loss in the Dorsum of the Hand.
What interventions are being tested in trial NCT02904096?
The interventions under investigation include: Radiesse injectable implant and 2% lidocaine HCL (DEVICE).
Who is sponsoring clinical trial NCT02904096?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02904096 being conducted?
This trial has 9 study locations across California, New York, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Volume Loss in the Dorsum of the Hand
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.